Walvax BioTech (300142) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.003x

Based on the latest financial reports, Walvax BioTech (300142) has a cash flow conversion efficiency ratio of -0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-33.52 Million ≈ $-4.91 Million USD) by net assets (CN¥10.94 Billion ≈ $1.60 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Walvax BioTech market cap and net worth for the company's overall valuation and market capitalisation.

Walvax BioTech - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Walvax BioTech's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Walvax BioTech Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Walvax BioTech ranked by their cash flow conversion efficiency. Explore cash flow quality index of Walvax BioTech to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Jilin Aodong Pharmaceutical Group Co Ltd SHE:000623	0.004x
Mr D I Y Group M Bhd KLSE:5296	0.142x
Maximus Inc NYSE:MMS	-0.103x
Huada Automotive Tech Corp Ltd SHG:603358	-0.010x
FS KKR Capital Corp NYSE:FSK	-0.002x
PENNON GROUP PLC UNS.ADR2 F:3PN0	N/A
Provident Financial Services Inc NYSE:PFS	0.041x
XJ Electric Co Ltd SHE:000400	0.059x

Annual Cash Flow Conversion Efficiency for Walvax BioTech (2007–2025)

The table below shows the annual cash flow conversion efficiency of Walvax BioTech from 2007 to 2025. View Walvax BioTech (300142) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥9.81 Billion ≈ $1.44 Billion	CN¥494.37 Million ≈ $72.34 Million	0.050x	-44.07%
2024-12-31	CN¥11.51 Billion ≈ $1.68 Billion	CN¥1.04 Billion ≈ $151.68 Million	0.090x	-9.47%
2023-12-31	CN¥11.40 Billion ≈ $1.67 Billion	CN¥1.13 Billion ≈ $165.91 Million	0.099x	-8.99%
2022-12-31	CN¥10.99 Billion ≈ $1.61 Billion	CN¥1.20 Billion ≈ $175.82 Million	0.109x	+55.00%
2021-12-31	CN¥10.00 Billion ≈ $1.46 Billion	CN¥705.28 Million ≈ $103.20 Million	0.071x	+384.76%
2020-12-31	CN¥7.85 Billion ≈ $1.15 Billion	CN¥114.19 Million ≈ $16.71 Million	0.015x	+32.94%
2019-12-31	CN¥5.67 Billion ≈ $829.11 Million	CN¥62.02 Million ≈ $9.08 Million	0.011x	+188.30%
2018-12-31	CN¥5.26 Billion ≈ $770.02 Million	CN¥-65.23 Million ≈ $-9.54 Million	-0.012x	-335.34%
2017-12-31	CN¥3.56 Billion ≈ $520.57 Million	CN¥-10.13 Million ≈ $-1.48 Million	-0.003x	+88.84%
2016-12-31	CN¥3.52 Billion ≈ $515.62 Million	CN¥-89.94 Million ≈ $-13.16 Million	-0.026x	-11.19%
2015-12-31	CN¥3.02 Billion ≈ $442.47 Million	CN¥-69.41 Million ≈ $-10.16 Million	-0.023x	-11.83%
2014-12-31	CN¥3.21 Billion ≈ $470.01 Million	CN¥-65.93 Million ≈ $-9.65 Million	-0.021x	+50.45%
2013-12-31	CN¥2.94 Billion ≈ $429.99 Million	CN¥-121.73 Million ≈ $-17.81 Million	-0.041x	-267.52%
2012-12-31	CN¥3.17 Billion ≈ $463.81 Million	CN¥78.38 Million ≈ $11.47 Million	0.025x	-27.05%
2011-12-31	CN¥2.71 Billion ≈ $397.06 Million	CN¥91.98 Million ≈ $13.46 Million	0.034x	-0.28%
2010-12-31	CN¥2.55 Billion ≈ $373.28 Million	CN¥86.71 Million ≈ $12.69 Million	0.034x	-92.77%
2009-12-31	CN¥174.69 Million ≈ $25.56 Million	CN¥82.18 Million ≈ $12.03 Million	0.470x	+912.58%
2008-12-31	CN¥98.36 Million ≈ $14.39 Million	CN¥-5.69 Million ≈ $-833.30K	-0.058x	-103.21%
2007-12-31	CN¥17.66 Million ≈ $2.58 Million	CN¥31.85 Million ≈ $4.66 Million	1.804x	--

About Walvax BioTech

SHE:300142 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.04 Billion

CN¥20.81 Billion CNY

Market Cap Rank

#4877 Global

#815 in China

Share Price

CN¥13.01

Change (1 day)

-2.84%

52-Week Range

CN¥10.91 - CN¥16.10

All Time High

CN¥93.63